Results 241 to 250 of about 128,635 (269)

Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. [PDF]

open access: yesInflamm Bowel Dis
Sands BE   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy